Cargando…
Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
The second-generation antipsychotic drugs are widely used in the field of psychiatry, for an expanding number of different conditions. While their clinical efficacy remains indispensable, many of the drugs can cause severe metabolic side-effects, resulting in an increased risk of developing cardiome...
Autores principales: | Boyda, Heidi N., Pham, Michelle, Huang, Joyce, Ho, Amanzo A., Procyshyn, Ric M., Yuen, Jessica W. Y, Honer, William G., Barr, Alasdair M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886888/ https://www.ncbi.nlm.nih.gov/pubmed/35242029 http://dx.doi.org/10.3389/fphar.2022.765905 |
Ejemplares similares
-
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020) -
A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021) -
An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
por: Wu, Claire, et al.
Publicado: (2014) -
Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013) -
Association between Serum Lipids and Antipsychotic Response in
Schizophrenia
por: Kim, David D., et al.
Publicado: (2019)